Apimeds Pharmaceuticals US, Inc. - APUS
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$896K
QoQ value delta ($000)
+$250K
(+38.7%)
Implied price effect (QoQ)
+8.09%
Shares
Total shares
507,748
QoQ shares delta
+112,048
(+28.32%)
Total shares held by funds (by quarter)
Market chart (APUS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 6 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Hemenway Trust Co LLC | 490 | 274,000 | 0.04% |
| VANGUARD CAPITAL MANAGEMENT LLC | 171 | 95,929 | 0.0% |
| VANGUARD GROUP INC | 96 | 58,992 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 71 | 40,051 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 43 | 24,039 | 0.0% |
| TWO SIGMA SECURITIES, LLC | 18 | 10,550 | 0.0% |
| UBS Group AG | 7 | 4,187 | 0.0% |